Udo Jeschke

Suggest Changes
Learn More
Adjuvant anthracycline-based chemotherapy (AbCTX) is a standard treatment for patients with primary breast cancer. Its main target is topoisomerase IIα (TopIIa), a nuclear protein which is important(More)
The Thomsen-Friedenreich (TF) antigen (or, more precisely, epitope Galβ1–3GalNAcα-O-) has been known for a long time as a carcinoma-associated antigen. In normal tissues the occurrence of TF antigen(More)